m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia

BACKGROUND: N6-methyladenosine (m6A) has been confirmed to function critically in acute myeloid leukemia (AML) progression. Hitherto, the subtyping and prognostic predictive significance of m6A-correlated genes in AML is unclear. METHOD: From The Cancer Genome Atlas (TCGA-LAML), Therapeutically Appl...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Caizhu, Kou, Ruirui, Meng, Jie, Jiang, Duanfeng, Zhong, Ruilan, Dong, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436408/
https://www.ncbi.nlm.nih.gov/pubmed/37596597
http://dx.doi.org/10.1186/s12920-023-01629-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436408/
https://www.ncbi.nlm.nih.gov/pubmed/37596597
http://dx.doi.org/10.1186/s12920-023-01629-1

Ejemplares similares